Clinical Development

ZAIDYN Clinical Development software leverages AI and advanced clinical trial analytics to assist life sciences companies in designing clinical trial protocols and modeling trial feasibility. This platform aims to accelerate drug development by breaking down silos through the integration of data, technology, and analytics.

The platform is designed to shape the future of clinical research with an end-to-end planning approach that is smarter and more efficient. By utilizing AI and machine learning, it facilitates faster study planning and streamlines clinical trial data management. The platform enhances connectivity, collaboration, and patient-centricity, thereby raising the standards for clinical research.

Key benefits include a significant increase in adherence to data-driven recommendations, with an expected 70% improvement. Additionally, there is a projected 10% increase in the number of patients per site by 2025.

Features

• Study Feasibility: Enables the selection of optimal sites and countries for studies, setting clinical trials on a continuous improvement cycle. It provides a reliable clinical trial data management solution that supports advanced analytics and informs study feasibility decisions.
• Enrollment Forecasting: Offers a clinical trial solution that delivers dependable data, insights, and adaptable analytics. It empowers teams to forecast changes, model scenarios, and predict challenges, allowing for quick pivots and smarter decision-making throughout the study planning process.

ZAIDYN Clinical Development is part of a suite of products that includes ZAIDYN Commercial, which uses AI to drive commercial success, and ZAIDYN Connected Health, which enhances healthcare experiences and outcomes. The ZAIDYN Marketplace offers access to ZS’s latest life sciences applications, algorithms, and proprietary data sets.

ZS provides comprehensive support for clients from initial setup to ongoing usage, with dedicated software technical support included in the license fees for all applications.